The use of levetiracetam in monotherapy in post-stroke seizures in the elderly population;Uso del levetiracetam en monoterapia en crisis postictus de la población anciana

Revista de Neurologia

Volumn 45, Issue 9, 2007, Pages 523-525

  García Escrivá, Alejandro ^a,c   Lopez Hernandez N ^b  

^a Hospital de Levante   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^c NONE   (Spain)

Author keywords

Effectiveness; Elderly; Epilepsy; Levetiracetam; Monotherapy; Safety; Stroke

Indexed keywords

ETIRACETAM;

ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MALE; MONOTHERAPY; POSTSTROKE SEIZURE; PROSPECTIVE STUDY; SEIZURE; SOMNOLENCE; TREATMENT DURATION;

EID: 37349100873     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4509.2007365     Document Type: Article

References (15)

1. Gareri P, Gravina T, Ferreri G, De Sarro G. Treatment of epilepsy in the elderly. Prog Neurobiol 1999; 58: 389-407.
2. Sirven JL. Epilepsy in older adults: causes, consequences and treatment. J Am Geriatr Soc 1998; 46: 1291-301.
3. Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke 2004; 35: 1769-75.
4. Rowan AJ. Reflections on the treatment of seizures in the elderly population. Neurology 1998; 51 (Suppl 4): S28-33.
5. French J. Use of levetiracetam in special population. Epilepsia 2001; 42 (Suppl 4): 40-3.
6. Villanueva V, Gómez-Caigoya A, Gutiérrez-Delicado E, Serratosa, JM. Estudio abierto, prospectivo y observacional de eficacia y tolerabilidad con levetiracetam durante un año de seguimiento. Neurología 2007; 22: 348-53.
7. Stepien K, Tornaszewski M, Czuczwar SJ. Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs. Pharmacol Rep 2005; 57: 719-33.
8. Bradford JM, Sandercock P, Dennos M, Burn M, Warlow C. Classification and natural history of clinically identifiable subtypes of acute cerebral infarction. Lancet 1991; 337: 1521-6.
9. Alsaadi T M, Koopmans S, Apperson M, Farias S. Levetiracetam monotheraphy for elderly patients with epilepsy. Seizure 2004; 13: 58-60.
10. Alsaadi TM, Schatzel, Vinter Márquez A, Jorgensen J, Farias S. Clinical experience of levetiracetam monotheraphy for adults with epilepsy: 1-year follow-up study. Seizure 2005; 14: 139-42.
11. Ben-Menachem E, Falter U. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotheraphy. Epilepsia 2000; 41: 1276-83.
12. Ferrendelli JA, French J, Leppik I, Morrell MJ, Herbeuval A, Han J, et al. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial. Epilepsy Behav 2003; 4: 702-9.
13. Natale E, Tata MR, Guizzaro A, Didato G, Urso L, Brighina F, et al. Levetiracetam nel trattamento delle epilepssie vascolari: studio aperto. Dati preliminari. Boll Lega It Epil 2004; 125/126: 221-3.
14. Falip M, Carreño M, Amaro S, Donaire A, Delgado R, Toledo M, et al. Use of levetiracetam in hospitalized patients. Epilepsia 2006; 47: 2186-8. 15. UCB Pharma Inc. Smyrna, GA, 1999.
15. Berges S, Moulin T, Berger E, Tatu L, Sablot D, et al. Seizures and epilepsy following strokes: recurrence factors. Eur Neurol 2000; 43: 3-8.